Amgen
Search results
2 days ago · Until today, only one drug, developed by Horizon Therapeutics (now acquired by Amgen), has been approved by the FDA in 2020 for treating adults with thyroid eye disease.
2 days ago · Until today, only one drug, developed by Horizon Therapeutics (now acquired by Amgen), has been approved by the FDA in 2020 for treating adults with thyroid eye disease.
2 days ago · Sci. Transl. Med. 16, eade8560 (2024). Although the past three decades have seen tremendous scientific progress and key paradigm shifts in the field of multiple sclerosis (MS), the quest to ...
4 days ago · Horizon Therapeutics filed a motion to dismiss a recent Tepezza lawsuit wherein the plaintiff claimed use of this thyroid eye disease medication resulted in permanent hearing loss. Horizon argues that the plaintiff's claims are preempted by federal law as they failed to illustrate that the defendant could have added warnings to the medication's ...
1 day ago · IL-12 is a key regulator of the T H 1 gene program in human and murine CD4 T cells ( 29, 41, 42 ). Hence, if IL-12 physiologically plays a role in the in vivo differentiation of human T fr cells, then this could be reflected by the presence of a T H 1 gene signature in bona fide T fr cells.
4 days ago · The biopharmaceutical company earned $945 million during the quarter, compared to the consensus estimate of $873.52 million. Horizon Therapeutics Public had a trailing twelve-month return on equity of 20.46% and a net margin of 12.02%. Horizon Therapeutics Public's quarterly revenue was up 7.8% compared to the same quarter last year.
1 day ago · CONFLICT OF INTEREST STATEMENT. SA is a neuroaudiological consultant to Pfizer. GC has served on advisory boards and/or been a consultant and/or clinical trial investigator for Algo Therapeutics, Augustine Therapeutics, Egetis Therapeutics, Eli Lilly, Hoba Therapeuticx, Nanosilical, Pfizer, Plasma Protein Therapeutic Association Europe, Toray Industries, UCB Biopharma, and Voluntis Digital ...
